apollo
0

Welcome User

Login/Sign Up

Home
Buy Medicines
Lab Tests
Doctor Consult
Circle Membership
insurance
Blogs
Contact Us
Privacy Policy
Return & Refunds
Need Help
Terms and Conditions
  1. Home
  2. Medicine

  3. Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, Pack of 1
Offers on medicine orders
All offers
axis icici
Written By Bayyarapu Mahesh Kumar , M Pharmacy
Reviewed By Dr Aneela Siddabathuni , MPharma., PhD

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml belongs to the class of GLP-1 receptor agonists, which is used for chronic weight management in adults with obesity or overweight associated with weight-related medical problems. It works by mimicking a natural hormone that regulates appetite and food intake, helping to reduce hunger and calorie consumption. Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is administered once weekly by subcutaneous injection. Like all medicines, this medicine can cause side effects, although not everybody gets them. Nausea, vomiting, diarrhea, constipation, abdominal discomfort, dizziness, and altered taste are common side effects associated with this medication.

Read more
rxMedicinePrescription drug

Whats That

tooltip

Also Explore

Momverse
Ask Apollo
insurance

Composition :

SEMAGLUTIDE-0.25MG

Manufacturer/Marketer :

Novo Nordisk India Pvt Ltd

Consume Type :

PARENTERAL

Return Policy :

Not Returnable

About Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml belongs to the class of medicines called GLP-1 receptor agonists used for chronic weight management in adults. It is prescribed alongside a reduced-calorie diet and increased physical activity to help achieve and maintain weight loss in patients with obesity (BMI ≥30 kg/m²) or overweight (BMI ≥27 kg/m²) who have weight-related health conditions such as type 2 diabetes, high blood pressure, or abnormal cholesterol levels. Obesity and overweight are chronic conditions that increase the risk of serious health problems, including heart disease, stroke, and diabetes.

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation. It works by slowing down gastric emptying, increasing the feeling of fullness, and reducing food cravings, which helps lower overall calorie intake. By regulating appetite and digestion, it aids in long-term weight management and improves associated metabolic conditions.

A healthcare expert will administer or guide you on how to inject Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml correctly. It is given once weekly as a subcutaneous injection under the skin in the abdomen, thigh, or upper arm. Kindly do not attempt to self-administer without proper training from a healthcare professional. In some cases, Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml may cause side effects such as nausea, vomiting, diarrhoea, constipation, abdominal discomfort, dizziness, or altered taste, which usually improve over time.

It is recommended not to use Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml if you or a close family member have ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), a condition known as Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have ever had a severe allergic reaction to semaglutide or any of its ingredients. Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml should also not be used during pregnancy, while breastfeeding, or in children under 12 years of age. Before starting treatment, inform your doctor if you have a history of pancreatitis, kidney or liver problems, diabetic eye disease (retinopathy), or stomach or intestinal disorders, so your doctor can carefully assess whether Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is safe and appropriate for you.

Uses of Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is used to treat various medical conditions. The detailed uses are as follows:

Chronic weight management: Used in adults with obesity or overweight with associated comorbidities to help achieve and maintain long-term weight loss.

Cardiovascular risk reduction: Used to lower the risk of major adverse cardiovascular events such as heart attack or stroke in adults with obesity or overweight and established heart disease.

Directions for Use

A qualified healthcare professional will instruct you on how to administer Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml. It is a once-weekly subcutaneous injection in the abdomen, thigh, or upper arm. It should not be injected intravenously or intramuscularly. The recommended dose is gradually increased over several weeks before reaching the maintenance dose as advised by your doctor. Kindly do not self-administer without proper training and medical guidance.

Medicinal Benefits

  • Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone responsible for regulating appetite and digestion.
  • It helps reduce calorie intake by slowing gastric emptying, increasing feelings of fullness, and decreasing hunger and food cravings, thereby supporting weight loss.
  • Promotes long-term weight management when combined with a reduced-calorie diet and physical activity, helping patients achieve and maintain a healthy body weight.
  • Improves metabolic health by aiding in better blood sugar control, lowering cholesterol levels, and reducing blood pressure in patients with obesity or overweight.
  • Reduces cardiovascular risk by lowering the chance of major heart-related events (such as heart attack or stroke) in adults with established heart disease who are overweight or obese.

How Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml Works

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml contains semaglutide, a GLP-1 receptor agonist that mimics a natural hormone involved in appetite regulation. It slows gastric emptying, increases feelings of fullness, and reduces food cravings, leading to reduced calorie intake and weight loss. Additionally, it helps improve blood sugar control and reduces the risk of cardiovascular events in high-risk patients.

Storage

•Store in a refrigerator (2°C to 8°C).
•Do not freeze or use if previously frozen.
•After first use, may be stored below 30°C or in a refrigerator (2°C to 8°C).
•Keep this medicine out of the sight and reach of children.

What if I have taken an overdose of Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml

As Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is a parenteral formulation, the chance of overdose may be less. However, accidental administration of more than the recommended dose may lead to severe nausea, vomiting, or low blood sugar levels. In case of overdose, patients must be closely monitored for symptoms, and appropriate supportive treatment should be given.

Drug Warnings

  • It is recommended not to use Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml if you or a close family member has ever had a type of thyroid cancer called medullary thyroid carcinoma (MTC), if you have Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or if you have ever experienced a severe allergic reaction to semaglutide or any of its ingredients.
  • Let your doctor know about all your medical conditions before using Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, including if you have or have ever had pancreatitis (inflamed pancreas), gallbladder problems or gallstones, kidney disease, severe digestive issues like gastroparesis (slow stomach emptying), diabetic eye disease (retinopathy), or any mental health concerns such as depression or suicidal thoughts.
  • Inform your doctor about every medicine, vitamin, or herbal supplement you are taking, as Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml may change how other medicines are absorbed. For instance, using Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml with insulin or sulfonylureas can increase the risk of low blood sugar, so your doctor may need to adjust other treatments.
  • Do not use Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml if you are pregnant, planning pregnancy, or breastfeeding. Stop the medicine at least 2 months before trying to conceive due to its long-lasting effect in the body. If you find out you are pregnant while using Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, stop it immediately and call your doctor.
  • Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is not recommended for children under 12 years old, because its safety has not been fully established.
  • Contact your doctor immediately if you experience any severe or persistent side effects, such as ongoing stomach pain (which may signal pancreatitis), signs of an allergic reaction (swelling, rash, difficulty breathing), severe vomiting or diarrhoea leading to dehydration, or mood changes such as depression or suicidal thoughts.

Diet & Lifestyle Advise

  • Follow a calorie-controlled, balanced diet as advised by your doctor or dietitian. This is essential for weight loss and to maximise the effect of Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml.
  • Choose high-fibre, nutrient-dense foods like vegetables, fruits, whole grains, and lean proteins. These help you feel full longer and support blood sugar control.
  • Avoid high-sugar and high-fat foods, which can slow weight loss and affect blood sugar levels. Limit processed snacks, fried foods, and sugary drinks.
  • Eat smaller, frequent meals and chew slowly to reduce nausea and discomfort, as Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml slows stomach emptying.
  • Stay hydrated by drinking plenty of water throughout the day. This helps prevent dehydration, especially if you experience vomiting or diarrhea, which are possible side effects.
  • Limit or avoid alcohol, as it can increase the risk of low blood sugar (if you have diabetes or take insulin/sulfonylureas) and may worsen gastrointestinal side effects.
  • Be physically active for at least 150 minutes a week (e.g., brisk walking, cycling, swimming), as regular exercise enhances weight loss and improves blood pressure, cholesterol, and blood sugar.
  • Monitor your blood sugar regularly if you have type 2 diabetes or are taking other diabetes medications, as weight loss and Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml may change your insulin needs.
  • Keep regular follow-up appointments so your doctor can track your progress, adjust your dose if necessary, and check for side effects or complications.
  • Adopt long-term healthy habits, to help keep the weight off after stopping Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml, continue following a healthy diet and regular physical activity.

Habit Forming

No

Therapeutic Class

MISCELLANEOUS
bannner image

Alcohol

Caution

You are recommended to avoid alcohol consumption while taking Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml. It could lead to increased adverse events.

bannner image

Pregnancy

Unsafe

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml should not be used during pregnancy as there is a potential risk of harm to the unborn baby. Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is not recommended for women who are pregnant, planning to conceive soon, or not using reliable contraception during therapy.

bannner image

Breast Feeding

Unsafe

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is not recommended during breastfeeding as its safety is not established.

bannner image

Driving

Caution

Generally does not impair ability to drive; however, dizziness or low blood sugar (if combined with other drugs) may affect alertness.

bannner image

Liver

Caution

Inform your doctor before receiving Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml if you have a pre-existing or a history of liver disease. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Kidney

Caution

Inform your doctor before receiving Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml if you have a pre-existing or a history of kidney disease. Your doctor will prescribe only if the benefits outweigh the risks.

bannner image

Children

Unsafe

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is not recommended for children as efficacy and safety have not been established.

Have a query?

FAQs

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml is used for long-term weight management in adults with obesity or overweight with related medical conditions and to reduce cardiovascular risks.

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml works by mimicking the GLP-1 hormone, which increases satiety, reduces hunger, and slows digestion, leading to lower calorie intake and weight loss.

The most common side effects include nausea, vomiting, diarrhoea, constipation, abdominal discomfort, and dizziness, usually improving over time.

No, it should not be used during pregnancy or breastfeeding. It must be stopped at least 2 months before planning pregnancy.

Wegovy Flextouch 0.25 mg PFP Combipack Injection 1.5 ml should not be taken with other GLP-1 receptor agonists or weight-loss products unless specifically advised by your doctor.

There are no strict dietary restrictions, but alcohol should be limited as it may worsen gastrointestinal symptoms or increase hypoglycemia risk.

Country of origin

India

Manufacturer/Marketer address

Plot No.32, 47-50, Epip Area, Whitefield, Bangalore - 560 066
Other Info - WEG0022

Disclaimer

While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
icon image

Keep Refrigerated. Do not freeze.

Author Details

Bayyarapu Mahesh KumarDoctor badge

Written By

Bayyarapu Mahesh Kumar

M Pharmacy

Dr Aneela SiddabathuniDoctor badge

Reviewed By

Dr Aneela Siddabathuni

MPharma., PhD

Last Updated

Jul 31, 2025 | 8:42 AM IST

Doctor imageWe provide you with authentic, trustworthy and relevant information

Reference

  1. https://www.wegovy.com/
  2. https://www.novo-pi.com/wegovy.pdf
  3. https://www.drugs.com/drug-interactions/semaglutide-index.html?filter=3

Buy best Diabetics products by

whatsapp Floating Button
Buy Now
Add to Cart